[1] 潘剑,王杞章,刘济远.双膦酸盐相关性颌骨坏死[J].华西口腔医学杂志,2017,35(1):29-36.
[2] Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic[J]. J Oral Maxillofac Surg, 2003,61(9):1115-1117.
[3] 武永刚,段力军,王坤正.血管内皮生长因子在激素性骨坏死过程中的变化特点[J].中国组织工程研究与临床康复,2010,14(7):1204-1207.
[4] Vincenzi B, Napolitano A, Zoccoli A, et al. Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw[J]. J Hematol Oncol, 2012,5:56.
[5] Silva ML, Tasso L, Azambuja AA, et al. Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy-histomorphometric and immunohistochemical analysis[J]. Clin Oral Investig, 2017, 21(1):199-210.
[6] L?觝rincz T, Tím?觃r J, Szendr?觝i M. Alterations of microvascular density in bone metastases of adenocarcinomas[J]. Pathol Oncol Res, 2004,10(3):149-153.
[7] Sharma D, Ivanovski S, Slevin M, et al. Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect[J]. Vasc Cell, 2013,5(1):1.
[8] Endo Y, Kumamoto H, Nakamura M, et al. Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ)[J]. Biol Pharm Bull, 2017,40(6):739-750.
[9] 魏斌,孙国文.双膦酸盐及其相关性颌骨坏死的机制和治疗[J].国际口腔医学杂志,2016,43(4):445-448.
[10] He LH, Xiao E, An JG, et al. Role of Bone marrow stromal cells in impaired bone repair from BRONJ osseous lesions[J]. J Dent Res, 2017,96(5):539-546.
[11] Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American society for bone and mineral research[J]. J Bone Miner Res, 2007, 22(10):1479-1491.
[12] Walter C, Pabst A, Ziebart T, et al. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro[J]. Oral Dis, 2011,17(2):194-199.
[13] Stresing V, Fournier PG, Bellahcène A, et al. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase[J]. Bone, 2011,48(2):259-266.
[14] Tang X, Zhang Q, Shi S, et al. Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells[J]. Int J Cancer, 2010,126(1):90-103.
[15] Soki FN, Li X, Berry J, et al. The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches[J]. J Cell Biochem, 2013,114(1):67-78.
[16] 魏斌,孙国文.双膦酸盐及其相关性颌骨坏死的机制和治疗[J].国际口腔医学杂志,2016,43(4):445-448.
[17] 方海军,谷志远.转化生长因子-β1和血管内皮生长因子在兔下颌骨缺损修复中的表达[J].国际口腔医学杂志,2009,36(6):650-654.
[18] Choi H, Lee JH, Kim HJ, et al. Genetic association between VEGF polymorphisms and BRONJ in the Korean population [J]. Oral Dis, 2015, 21(7):866-871.
[19] Carneiro NS, Armada L, Pereira DL, et al. Evaluation of KGF, EGF, VEGF, bcl-2, IL-6 and ki67 expression in oral epithelium adjacent to bisphosphonate-related osteonecrosis and florid osseous dysplasia: a comparative immunohistochemical study[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017,124(6):548-553. |